Updated:
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001818794, and its reported industry...
Overview
Dyne Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001818794, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-03-02, it reported net income of USD -446,214,000; total assets of USD 1,186,958,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Dyne Therapeutics, Inc.
- Classification
- Public company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Waltham, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- Ticker
- Nasdaq: DYN
- SEC CIK
- 0001818794
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2025USD | -$446.2M | $1.2B | $893.4M | -$403.2M | |
| FY2024USD | -$317.4M | $691.2M | $435.4M | -$292.4M | |
| FY2023USD | -$235.9M | $165.1M | $121.6M | -$188.2M | |
| FY2022USD | -$168.1M | $306.3M | $172.1M | -$153.6M |
FY2025. Net income: shown as originally filed; later filings report different values for the same periods.
FY2024. Net income: shown as originally filed; later filings report different values for the same periods.
FY2023. Net income: shown as originally filed; later filings report different values for the same periods.
FY2022. Net income: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| DEF 14A | DEF 14A |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Dyne Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.